Traditional Chinese medicine and lung cancer-From theory to practice

With the continuous breakthroughs in molecular biology and biochemistry, we have constantly made great progress in the treatment of lung cancer. There is no doubt that standard treatment (such as surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy) has greatly improved the prognosis of lung cancer populations. In particular, the immunotherapy has brought more and more good news to countless lung cancer patients. In contrast to these standard treatments, traditional Chinese medicine (TCM) rarely has a profound and comprehensive overview in the field of lung cancer. This article will summarize the latest progress of TCM in lung cancer which is mainly non-small cell lung cancer (NSCLC) from theory to clinical practice, which would carry forward the sophisticated TCM and promote the development of modern medicine.

Automated summary

With continuous breakthroughs in molecular biology and biochemistry, significant progress has been made in the treatment of lung cancer, particularly with standard treatments improving patient prognosis and immunotherapy providing positive outcomes. In contrast, traditional Chinese medicine has limited research in the field of lung cancer, but has shown progress in non-small cell lung cancer.